If you're struggling like I was, dont give up

When you come in asking about semaglutide near you, heres what you can expect: Comprehensive evaluation Detailed medical history and medication review Discussion of your weightloss history, goals, and challenges Review of family history and any prior reactions to medications Baseline labs and screening (when appropriate) Blood work to assess kidney function, liver function, blood sugar, and cholesterol Screening for thyroid disease, pancreatitis risk, and other conditions that may affect safety Individualized prescription plan Careful determination of whether semaglutide is appropriate and safe for you Starting at a low dose and gradually increasing based on how your body responds Clear instructions on injection technique, timing, and what to expect in the first weeks Ongoing monitoring Regular followups to track weight, side effects, blood pressure, and labs as needed Dose adjustments based on progress and tolerance Guidance on when to pause, continue, or transition off semaglutide This is not a pay and get a shot modelit is a physiciandirected medical program where semaglutide is one tool, not the entire plan

We extracted the following 30 factors: age, sex, body mass index (BMI), race (Asian, American Indian or Alaska Native, Black or African American, Native Hawaiian or Other Pacific Islander, White, Other Race, unknown), diagnoses (heart failure, ischemic heart diseases, old myocardial infarction, atrial fibrillation and flutter, hypertension, dyslipidemia, chronic kidney disease, cerebral infarction), and medication (be-ta blockers, diuretics, mineralocorticoid receptor antagonists [MRA], angiotensin converting enzyme [ACE] inhibitors, angiotensin II receptor blockers [ARB], sacubitril, statins, metformin, sulfonylureas, sodium-glucose co-transporter 2 [SGLT2] inhibitors, insulin, laboratory (systolic blood pressure, diastolic blood pressure, glomerular filtration rate [GFR], hemoglobin, albumin, LDL cholesterol, hemoglobin A1c [HbA1c])

In our program we tell patients to plan on roughly 12 to 15% with semaglutide and 18 to 22% with tirzepatide, with the dose titrated monthly over four to six months on semaglutide and five to seven on tirzepatide